New Journey Health Technology Group Co.,LTD (SHE:002219)

Market Cap	7.57B -2.9%
Revenue (ttm)	2.87B -15.2%
Net Income	32.69M -44.6%
EPS	0.01 -45.6%
Shares Out	3.44B
PE Ratio	218.19
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	116,392,200
Open	2.220
Previous Close	2.190
Day's Range	2.170 - 2.260
52-Week Range	1.690 - 2.970
Beta	0.21
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About SHE:002219

New Journey Health Technology Group Co.,LTD, together with its subsidiaries, provides medical services and pharmaceuticals products in China and internationally. The company operates regional medical centers to treat aging diseases, such as oncology, cardiovascular, cerebrovascular, and orthopedics. It is also involved in the research, development, production, and sale of medicines comprising Duyiwei capsules, Ginsengqi Astragalus and Schisandra tablets, Maiping tablets, Qianlie Antong tablets, Prosta Antong tablets, Gongliuning capsules, cough...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2001
• Employees: 8,843
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002219

Financial Performance

In 2025, SHE:002219's revenue was 3.05 billion, a decrease of -19.64% compared to the previous year's 3.80 billion. Earnings were 30.94 million, a decrease of -73.04%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 26, 2026

Data Sources Report a data error